| 
Description of Research: Daniel Kaul
INFECTIONS IN TRANSPLANT PATIENTS
Dr. Kaul directs the Transplant Infectious Disease
Service that provides inpatient and outpatient consultation
for patients who have received either solid organ
or stem cell transplants. We also work closely with
the various transplant groups preparing prophylactic
and treatment guidelines. Research interests include
the epidemiology of opportunistic infections after
solid organ transplantation and the diagnosis and
management of viral and other opportunistic infections
after stem cell transplantation.
HIV/AIDS
Dr. Kaul is a member of the HIV/AIDS Treatment Program
and spent two years training specifically in this
area and has been a principal investigator on phase
II, III, and IV multi-center trials of antiretroviral
agents. Research interests include clinical use of
antiretroviral therapies, immune reconstitution disease,
and resistance to antiretroviral agents.
RECENT PUBLICATIONS
Kaul DR, Jordan, M. Diffuse Infiltrative Lymphocytosis
Syndrome in an HIV-Positive Patient. Infections in
Medicine 2006 September, 23 (9): 412-414.
Kaul DR, Flanders SA, Beck JM, Saint S. The incidence,
etiology, risk factors, and outcome of hospital-acquired
fever: A systematic, evidence-based review. Journal
of General Internal Medicine 2006, 21 (11): 1184-87.
Safdar N, Kaul DR, Saint S. Into the Woods. New England
Journal of Medicine 2007, 356 (9): 943-947.
Safdar N, Kaul D, Saint S. Into the woods - The authors
reply. N Engl J Med 356 (23): 2429-2430, 2007.
Kaul DR, Orringer MB, Saint S, Jones SR. The Drenched
Doctor. New England Journal of Medicine 2007, 356
(18): 1871-1876.
Savona MR, Newton D, Frame D, Levine JE, Mineishi
S, Kaul DR. Low Dose Cidofovir Treatment of BK Virus
Associated Hemorrhagic Cystitis in Recipients of Hematopoietic
Stem Cell Transplants. Bone Marrow Transplantation
2007, Jun;39(12):783-7
Riddell J IV, Kaul DR, Karakousis PC, Gallant JE,
Mitty J, Kazanjian PH. Mycobacterium avium complex
immune reconstitution inflammatory syndrome: Long
term outcomes - art. no. 50. J Translat Med 5: 50,
2007.
Safdar N, Abad CL, Kaul DR, Jarrard D, Saint S. An
unintended consequence. N Engl J Med 358 (14): 1496-1501,
2008.
Nicolasora N, Kaul DR. Infectious disease emergencies.
Med Clin N Amer 92 (2): 427-441, 2008.
Falade OO, Antonarakis ES, Kaul DR, Saint S, Murphy
PA. Beware of first impressions (Clinical Problem
Solving). New Engl J Med 359 (6): 628-634, 2008.
Nicolasora NP, Reddy P, Kaul DR. Biopsy-proven adenoviral
diarrhea responding to low-dose cidofovir. Transpl
Infect Dis 10 (5): 346-350, 2008.
Kaul DR, Collins CD, Hyzy RC. New developments in
antimicrobial use in sepsis. Curr Pharm Design 14
(19): 1912-1920, 2008.
Kaul DR, Lowe L, Visvesvara GS, Farmen S, Khaled
YA, Yanik GA. Acanthamoeba infection in a patient
with chronic graft-versus-host disease occurring during
treatment with voriconazole. Transpl Infect Dis 10
(6): 437-441, 2008.
Collins CD, Ellis JJ, Kaul DR. Comparative cost-effectiveness
of posaconazole versus fluconazole or itraconazole
prophylaxis in patients with prolonged neutropenia.
Am J Health Syst Pharm 65 (23): 2237-2243, 2008.
Psarros G, Kaul DL, Kauffman CA. Disseminated histoplasmosis
in a heart transplant recipient: an uncommon diagnosis
even in the Midwest. Infect Dis Clin Pract 16:49-53,
2008.
Segal BH, Freifeld AG, Baden LR, Brown AE, Casper
C, Dubberke E, Gelfand M, Greene, JN, Ison MG, Ito
JI, Karp JE, Kaul DR, King E, Mackler E, Marcucci
G, Montoya JG, Engemann AM, Rolston K. Prevention
and Treatment of Cancer Related Infections. Journal
of the National Comprehensive Cancer Network 6(2):122-74,
2008.
Safdar N, Abad CL, Narayan S, Kaul DR, Saint S. Keeping
an Open Mind. New Engl J Med 360 (1): 72-76, 2009.
Peres E, Khaled Y, Krijanovski OI, Mineishi S, Levine
JE, Kaul DR, Riddell J. Mycobacterium chelonae necrotizing
pneumonia after allogeneic hematopoietic stem cell
transplant: report of clinical response to treatment
with tigecycline. Transpl Infect Dis 11:57-63, 2009.
Gandhi T, Flanders SA, Markovitz E, Saint S, Kaul
DR. Importance of Urinary Tract Infection to Antibiotic
Use Among Hospitalized Patients. Infect Contr Hosp
Epidemiol 30 (2): 193-195, 2009.
Cooke DT, Pagani FD, Kaul DR, Cooke KR, Lau CL, Riddell
J. Successful treatment of pulmonary zygomycosis in
two transplant recipients with liposomal amphotericin
B and partial surgical resection followed by posaconazole
(Letter). Mycoses eFIRST date: 12 FEB 2009.
|